New hope for dialysis patients with failing hearts?
NCT ID NCT07417215
Summary
This study is testing if a medication called sacubitril/valsartan can improve heart function in people who are on long-term dialysis and have a common type of heart failure (HFpEF). The drug is already used for other heart conditions but is not approved for patients on dialysis. Researchers will compare 60 patients, with half receiving the new drug and half receiving standard care, to see if it helps their hearts work better.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Clinical Hospital Mostar
Mostar, 88000, Bosnia and Herzegovina
Conditions
Explore the condition pages connected to this study.